Orion Oyj
OMXH:ORNBV
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
32.27
49.77
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Orion Oyj
Cash from Financing Activities
Orion Oyj
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
Orion Oyj
OMXH:ORNBV
|
Cash from Financing Activities
-€65.2m
|
CAGR 3-Years
37%
|
CAGR 5-Years
28%
|
CAGR 10-Years
11%
|
|
|
H
|
Herantis Pharma Oyj
OMXH:HRTIS
|
Cash from Financing Activities
€4.5m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Orion Oyj
Glance View
Orion Oyj, a Finnish pharmaceutical and diagnostics company, has a storied history that dates back to 1917, when it was formed to meet the healthcare needs of the Finnish population. Over the decades, Orion has evolved into a key player in the European healthcare landscape, driven by its commitment to innovation and high-quality products. The company operates in two main segments: Prescription Pharmaceuticals, which includes medication for various therapeutic areas such as pain management, oncology, and neurology; and Animal Health, offering veterinary medicines and healthcare solutions. With a robust pipeline of new drugs and a focus on research and development, Orion is well-positioned to address the growing global demand for effective healthcare solutions. For investors, Orion presents a compelling narrative of stability and growth. The company has achieved consistent revenue growth and profitability, bolstered by strategic partnerships and an expansive international market presence. Orion maintains a strong balance sheet, allowing it to invest in future innovation while returning value to shareholders through dividends. The demand for its products is supported by an aging population and increasing health challenges, creating a favorable environment for sustained demand. In a rapidly changing world, Orion Oyj stands out as a resilient and adaptive company, embodying the prudent investment strategy espoused by legends like Warren Buffett and Charlie Munger.
See Also
What is Orion Oyj's Cash from Financing Activities?
Cash from Financing Activities
-65.2m
EUR
Based on the financial report for Jun 30, 2024, Orion Oyj's Cash from Financing Activities amounts to -65.2m EUR.
What is Orion Oyj's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
11%
Over the last year, the Cash from Financing Activities growth was 77%. The average annual Cash from Financing Activities growth rates for Orion Oyj have been 37% over the past three years , 28% over the past five years , and 11% over the past ten years .
You don't have any saved screeners yet
